PMID- 32945173 OWN - NLM STAT- MEDLINE DCOM- 20210127 LR - 20210127 IS - 1940-1574 (Electronic) IS - 0003-3197 (Linking) VI - 72 IP - 2 DP - 2021 Feb TI - Impact of the Timing of Foot Tissue Resection on Outcomes in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia. PG - 159-165 LID - 10.1177/0003319720958554 [doi] AB - The objective of this study is to describe utilization of revascularization and tissue resection in patients with chronic limb-threatening ischemia (CLTI) and determine whether the timing of resection impacts outcomes. Revascularizations for CLTI were queried (ACS-NSQIP 2011-2015). Outcomes included 30-day major adverse limb events (MALE), major adverse cardiac events (MACE), length of stay (LOS), operative time, 30-day readmissions, and wound infections. Groups included revascularization alone, revascularization/tissue resection during the same procedure (concurrent), or revascularization/delayed tissue resection (delayed). Resections were debridement or transmetatarsal amputations. Multivariate logistic regression determined risk-adjusted effects of tissue resection on outcomes. There was no difference in overall 30-day MACE or MALE between groups (P = .70 and P = .35, respectively). Length of stay (6.1 days revascularization alone vs 7.8 days concurrent vs 8.7 days delayed, P < .0001) was longer in patients who underwent any tissue resection. Highest 30-day readmission and operative time was the concurrent group (P = .02 and P < .0001, respectively). Wound infection was highest in the delayed group (1.4% revascularization alone vs 1.3% concurrent vs 6.2% delayed, P < .0001). After risk adjustment, timing of resection did not impact LOS for concurrent and delayed groups compared to revascularization alone (both P < .0001). Debridement and minor amputations can be done concurrently in patients undergoing revascularization for CLTI. FAU - Shannon, Alexander H AU - Shannon AH AUID- ORCID: 0000-0003-2236-3120 AD - Department of Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - de Grijs, Derek P AU - de Grijs DP AD - Division of Vascular and Endovascular Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - Goudreau, Bernadette J AU - Goudreau BJ AUID- ORCID: 0000-0002-2954-113X AD - Department of Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - Mehaffey, J Hunter AU - Mehaffey JH AD - Department of Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - Cullen, J Michael AU - Cullen JM AUID- ORCID: 0000-0002-2225-9879 AD - Department of Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - Williams, Carlin AU - Williams C AD - Division of Vascular and Endovascular Surgery, 12350University of Virginia, Charlottesville, VA, USA. FAU - Robinson, William P 3rd AU - Robinson WP 3rd AD - Division of Vascular Surgery, East Carolina University, Greenville, NC, USA. LA - eng GR - T32 HL007849/HL/NHLBI NIH HHS/United States GR - U01 HL088925/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200918 PL - United States TA - Angiology JT - Angiology JID - 0203706 SB - IM MH - Adult MH - Aged MH - Chronic Disease MH - Endovascular Procedures/methods MH - Female MH - Humans MH - Ischemia/complications/*etiology MH - Length of Stay/statistics & numerical data MH - Lower Extremity/*physiopathology/surgery MH - Male MH - Middle Aged MH - Peripheral Arterial Disease/*complications/physiopathology MH - Postoperative Complications/*etiology MH - Risk Factors MH - Treatment Outcome MH - Vascular Grafting/methods OTO - NOTNLM OT - length of stay OT - limb ischemia OT - major adverse cardiac events OT - major adverse limb events OT - revascularization OT - tissue resection EDAT- 2020/09/19 06:00 MHDA- 2021/01/28 06:00 CRDT- 2020/09/18 08:42 PHST- 2020/09/19 06:00 [pubmed] PHST- 2021/01/28 06:00 [medline] PHST- 2020/09/18 08:42 [entrez] AID - 10.1177/0003319720958554 [doi] PST - ppublish SO - Angiology. 2021 Feb;72(2):159-165. doi: 10.1177/0003319720958554. Epub 2020 Sep 18.